With a market capitalization (market cap) of $293.76B — a measure of how much the company is worth — Novartis AG is the 49th most valuable company in Healthcare as of August 19, 2026. Shares trade at $154.55, up +1.70% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Visit websiteAs of August 19, 2026, Novartis AG (NVS) is worth $293.76B — this is its market capitalization, the total value of all its outstanding shares.
Novartis AG’s market cap is $293.76B, which ranks it #49 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Novartis AG (NVS) shares trade at $154.55, up 1.70% on the day, as of August 19, 2026.
Novartis AG trades at a price-to-earnings (P/E) ratio of 21.3, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025